The Good Old Days Return for Housing Prices
McorpCX Inc. (TSX.V: MCX) Well Ahead in the Fast-Growing Customer Experience Market
Despite Trumps Best Efforts, Clinton Couldn’t Land the KO Punch
The Digital Age: Preparing Private Companies for Modern Investor Relations
Why Canadian Dollar Weakness is a Buy
Cameron Reynolds of VolitionRX Ltd. ($VNRX) sits down with Equities.com to discuss the company's blood-based diagnostic tests for cancer.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2016 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).